Cite
HARVARD Citation
Stamati, K. et al. (2020). The anti-angiogenic tyrosine kinase inhibitor Pazopanib kills cancer cells and disrupts endothelial networks in biomimetic three-dimensional renal tumouroids. Journal of tissue engineering. p. . [Online].